Celltrion: Celltrion Inc., a South Korean bio firm, announced plans to accelerate its shareholder-friendly policies, including the issuance of bonus shares.

According to Yonhap News Agency, the bio firm will issue 0.05 bonus shares per existing share, amounting to approximately 10,920,000 shares, as stated in its regulatory filing. In addition, the company intends to repurchase about 550,000 shares, valued at around 100 billion won (US$66.4 million). This buyback will contribute to a total of approximately 2 trillion won in stocks repurchased by the company this year.

Furthermore, Celltrion revealed that its largest shareholder, Celltrion Holdings Co., plans to acquire shares worth roughly 100 billion won of Celltrion Inc. The company had previously communicated its intention to explore various methods to enhance shareholder value, expressing concerns that the company might be undervalued by investors despite its strong business performance.